Annuaire des médecins

Le Docteur Pascual a débuté sa formation en pédiatrie et infectiologie pédiatrique à Buenos Aires en Argentine.

Depuis 2003, installé en Suisse il poursuit ce parcours qui e conduit à l'obtention d'un FMH en infectiologie et pédiatre.

Finalement, il se décide d'exercer en tant que pédiatre général, sa réelle passion et présente un intérêt particulier pour la pédiatrie ambulatoire et les urgences pédiatriques.

Le Docteur Pascual dirige l'Ecole de l'asthme de l'Hôpital de Nyon. 

• Ancien chef de clinique du DFME - CHUV Lausanne jusqu'en 2012

• Depuis 2012 | Médecin chef co-responsable du Service de Pédiatrie du GHOL

Unilateral headache with scalp and hair pain in an 8 year old boy
Camilla Antonsen, Marianthi Tsingos, Andrés Pascual MD
Pediatrics in Review, in press

Oxygène à haut flux dans la bronchiolite aiguë sévère hypoxémique : le traitement de première intention ?
Wannaz L, Christin L, Pascual A, Fumeaux T.
Rev Med Suisse. 2018 Jul 11;14(613):1372. French.

Clinical signs of hypoxaemia in children aged 2 months to 5 years with acute respiratory distress in Switzerland and Senegal.
von der Weid L, Gehri M, Camara B, Thiongane A, Pascual A, Pauchard JY.
Paediatr Int Child Health. 2018 May;38(2):113-120. doi: 10.1080/20469047.2017.1390828. Epub 2017 Nov

[News in paediatrics].Depallens S, Lutz N, Carlomagno R, Meyrat B, Barazzoni MS, Tchameni YY, Pascual A, Scerba F, Superti-Furga A.Rev Med Suisse. 2016 Jan 13;12(500):71-4. French

Pascual A, Csajka C, Buclin T, Bolay S, Bille J, Calandra T, and Marchetti O.
Challenging recommended oral and intravenous voriconazole doses for improved efficacy and safety: population pharmacokinetics-based analysis of adult patients with invasive fungal infections.
Clin Infect Dis. 2012 Aug; 55(3):381-90.
“Selected as one of the ICAAC Top Ten Mycology Papers. 52nd ICAAC, San Francisco, U.S.A., September 9-12, 2012”

Pascual A, Perez M-H, Jaton K; Wenger A, Krähenbühl J D, Hafen G, Di Bernardo S, Cotting J, Stucki P, Greub G, Vaudaux B
Mycoplasma hominis necrotizing pleuropneumonia in an immunocompetent adolescent.
BMC Infect Dis. 2010 Nov 24;10(1):335.

Rochat B, Pascual A, Pesse B, Lamoth F, Sanglard D, Decosterd L A, Bille J, Calandra T, Marchetti O.
Quantification by Ultra-Performance Liquid Chromatography Mass Spectrometry and Bioassay of the Variability of Posaconazole Plasma Concentrations after Oral Dosing.
Antimicrob Agents Chemother. 2010 Dec;54(12):5074-81.

Lamoth F, Buclin T, Pascual A, Vora S, Bolay S, Decosterd LA, Calandra T, Marchetti O.
High cefepime plasma concentrations and neurological toxicity in febrile neutropenic patients with mild impairment of renal function.
Antimicrob Agents Chemother. 2010 Oct;54(10):4360-7.

Pascual A, Jaton-Ogay K, Ninet B, Bille J, and Greub G.
New Diagnostic Real-Time PCR for Specific Detection of Mycoplasma hominis DNA.
Int J Microbiol. 2010; pii: 317512. doi: 10.1155/2010/317512.

Lamoth, F; Buclin, T; Pascual, A; Calandra, T; Marchetti, O.
Imipenem Underdosing as a Cause of Persistent Neutropenic Fever?
J Antimicrob Chemother. 2009 Sep;64(3):665-7.

Senn L, Eggimann P, Ksontini R, Pascual A, Demartines N, Bille J Calandra T and Marchetti O.
Caspofungin for prevention of intra-abdominal candidiasis in high-risk surgical patients.
Intensive Care Med. 2009 May; 35(5):903-8.

Lamoth F, Buclin T, Csajka C, Pascual A, Calandra T, Marchetti O.
Reassessment of recommended imipenem doses in febrile neutropenic patients with hematological malignancies.
Antimicrob Agents Chemother. 2009 Feb;53(2):785-7.

Andres D, Pascual A, Marchetti O.
Antifungal therapeutic drug monitoring: established and emerging indications.
Antimicrob Agents Chemother. 2009 Jan;53(1):24-34.

Cuttelod M, Pascual A, Baur C, Audrey S; Cometta A, Osih R, Duchosal M A, Cavassini M.
Hemophagocytic syndrome after highly active antiretroviral therapy initiation: a life-threatening event related to immune restoration inflammatory syndrome?
AIDS. 2008 Feb
19; 22(4):549-51.

Pascual A, Calandra T, Bolay S, Buclin T, Bille J, Marchetti O.
Voriconazole Therapeutic Drug Monitoring in Patients with Invasive Mycoses Improves Efficacy and Safety Outcomes. Clin Infect Dis. 2008 Jan 15; 46(2):201-11.
“Selected as one of the key papers for the ICAAC/IDSA Literature Review 2008. 48th ICAAC, Washington D.C., U.S.A., October 25-28, 2008”.

Pascual A, Nieth V, Calandra T, Bille J, Bolay S, Decosterd L A,
Sanglard S, Marchetti O.
Variability of Voriconazole Plasma Levels Measured by New High-Performance Liquid Chromatography and Bioassay Methods.
Antimicrob Agents Chemother. 2007 Jan, 51(1):137-43.

Laham FR, Israele V, Casellas JM, Garcia AM, Lac Prugent CM, Hoffman SJ, Hauer D, Thumar B, Name MI, Pascual A, Taratutto N, Ishida MT, Balduzzi M, Maccarone M, Jackli S, Passarino R, Gaivironsky RA, Karron RA, Polack NR, Polack FP.
Differential production of inflammatory cytokines in primary infection with human metapneumovirus and with other common respiratory viruses of infancy.